Sarepta Therapeutics (SRPT) Gross Margin (2017 - 2026)
Sarepta Therapeutics' Gross Margin was 62.77% in Q2 2026, down 12.26 percentage points from 75.04% a year earlier and down 22.35 percentage points from the prior quarter.
Powered by 
Analysis
Sarepta Therapeutics (SRPT) Gross Margin (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Sarepta Therapeutics' Gross Margin was 59.09% through Jun 30, 2026, down 20.19 percentage points year-over-year; for FY2025, it came in at 61.81%, down 21.42 percentage points from FY2024.
- Gross Margin shows a five-year change of -26.46 percentage points (FY2020 to FY2025).
- In earlier years, Gross Margin was 83.22% in FY2024 (-4.69 pp), 87.91% in FY2023 (+2.91 pp), 85.00% in FY2022 (-1.18 pp) and 86.17% in FY2021 (-2.09 pp).
- Quarterly Gross Margin has moved between 9.98% (Q4 2025) and 88.87% (Q4 2023) over five years.
- Compared with a year earlier, Gross Margin was higher in 1 of the last eight quarters, with an average year-over-year change of -16.64 percentage points.
- The best year-over-year quarter for Gross Margin over five years was Q3 2023 (a gain of 6.19 percentage points); the worst was Q4 2025 (a drop of 69.92 percentage points).
- Per Business Quant data, SRPT's Gross Margin in the three quarters before Q2 2026 was 85.12% (Q1 2026), 9.98% (Q4 2025) and 62.25% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Sarepta Therapeutics | 1.99 Bn | -1.25 Bn | 251.87 Mn | 62.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 62.77% |
| Mar 31, 2026 | 85.12% |
| Dec 31, 2025 | 9.98% |
| Sep 30, 2025 | 62.25% |
| Jun 30, 2025 | 75.04% |
| Mar 31, 2025 | 81.53% |
| Dec 31, 2024 | 79.91% |
| Sep 30, 2024 | 80.37% |
| Jun 30, 2024 | 87.73% |
| Mar 31, 2024 | 87.77% |
| Dec 31, 2023 | 88.87% |
| Sep 30, 2023 | 88.84% |
| Jun 30, 2023 | 86.94% |
| Mar 31, 2023 | 86.19% |
| Dec 31, 2022 | 88.08% |
| Sep 30, 2022 | 82.65% |
| Jun 30, 2022 | 83.81% |
| Mar 31, 2022 | 85.09% |
| Dec 31, 2021 | 84.24% |
| Sep 30, 2021 | 87.62% |
API Access
Sarepta Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=SRPT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "SRPT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=SRPT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();